Cargando…

Role of CAR T Cell Metabolism for Therapeutic Efficacy

SIMPLE SUMMARY: Chimeric antigen receptor (CAR) T cell therapy has heralded a new era in cancer treatment, in particular for hematological malignancies. Despite the current progress in CAR T cell research and development, frequent occurrence of exhausted and/or terminally differentiated CAR T cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rial Saborido, Judit, Völkl, Simon, Aigner, Michael, Mackensen, Andreas, Mougiakakos, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658570/ https://www.ncbi.nlm.nih.gov/pubmed/36358860 http://dx.doi.org/10.3390/cancers14215442

Ejemplares similares

Human Double-Negative Regulatory T-Cells Induce a Metabolic and Functional Switch in Effector T-Cells by Suppressing mTOR Activity
por: Haug, Tabea, et al.
Publicado: (2019)

Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma
por: Zundler, Sebastian, et al.
Publicado: (2023)

The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome
por: Richter, Silja, et al.
Publicado: (2022)

Lipotoxicity as a Barrier for T Cell-Based Therapies
por: Böttcher-Loschinski, Romy, et al.
Publicado: (2022)

Thrombopoietin receptor agonists for acquired thrombocytopenia following anti-CD19 CAR-T-cell therapy: a case report
por: Baur, Rebecca, et al.
Publicado: (2021)

The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation
por: Jacobs, Benedikt, et al.
Publicado: (2020)

T-Cell Metabolism in Graft Versus Host Disease
por: Karl, Franziska, et al.
Publicado: (2021)

Linking Immunoevasion and Metabolic Reprogramming in B-Cell–Derived Lymphomas
por: Böttcher, Martin, et al.
Publicado: (2020)

CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
por: Jitschin, Regina, et al.
Publicado: (2018)

Bone marrow stroma cells promote induction of a chemoresistant and prognostic unfavorable S100A8/A9(high) AML cell subset
por: Böttcher, Martin, et al.
Publicado: (2022)

Cellular and humoral immune responses to SARS-CoV-2 vaccination in patients after CD19.CAR T-cell therapy
por: Reimann, Hannah, et al.
Publicado: (2022)

CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints
por: Böttcher, Martin, et al.
Publicado: (2022)

Human CD4(+) T cells specific for dominant epitopes of SARS‐CoV‐2 Spike and Nucleocapsid proteins with therapeutic potential
por: Verhagen, Johan, et al.
Publicado: (2021)

CAR T cells for treating autoimmune diseases
por: Blache, Ulrich, et al.
Publicado: (2023)

Accumulation of T-cell-suppressive PD-L1(high) extracellular vesicles is associated with GvHD and might impact GvL efficacy
por: Baur, Rebecca, et al.
Publicado: (2023)

CD137 (4-1BB) stimulation leads to metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity
por: Stoll, A., et al.
Publicado: (2021)

IL-21 modulates memory and exhaustion phenotype of T-cells in a fatty acid oxidation-dependent manner
por: Loschinski, Romy, et al.
Publicado: (2018)

Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL
por: Blumenberg, Viktoria, et al.
Publicado: (2023)

Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells
por: Bergmann, Christina, et al.
Publicado: (2023)

The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL
por: Rejeski, Kai, et al.
Publicado: (2022)

Hydrogen-Peroxide Synthesis and LDL-Uptake Controls Immunosuppressive Properties in Monocyte-Derived Dendritic Cells
por: Menzner, Ann-Katrin, et al.
Publicado: (2021)

Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy
por: Pellegrino, Marsha, et al.
Publicado: (2020)

Optimization of metabolism to improve efficacy during CAR-T cell manufacturing
por: Zhang, Meng, et al.
Publicado: (2021)

Control of PD-L1 expression in CLL-cells by stromal triggering of the Notch-c-Myc-EZH2 oncogenic signaling axis
por: Böttcher, Martin, et al.
Publicado: (2021)

The Induction of a Permissive Environment to Promote T Cell Immune Evasion in Acute Myeloid Leukemia: The Metabolic Perspective
por: Mougiakakos, Dimitrios
Publicado: (2019)

Regulatory T Cells in Colorectal Cancer: From Biology to Prognostic Relevance
por: Mougiakakos, Dimitrios
Publicado: (2011)

D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization
por: Böttcher, Martin, et al.
Publicado: (2018)

Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy
por: Nunez, Daniel, et al.
Publicado: (2023)

Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion
por: Rejeski, Kai, et al.
Publicado: (2023)

Engineering CAR T cells for enhanced efficacy and safety
por: Wu, Yiqian, et al.
Publicado: (2022)

Regulation of Energy Metabolism during Early B Lymphocyte Development
por: Urbanczyk, Sophia, et al.
Publicado: (2018)

Chimeric-Antigen-Receptor (CAR) T Cells and the Factors Influencing their Therapeutic Efficacy
por: Kravets, Victoria G, et al.
Publicado: (2017)

Lymphocyte Immune Response and T Cell Differentiation in Fontan Patients with protein-losing enteropathy
por: Moosmann, Julia, et al.
Publicado: (2021)

Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers
por: Kyte, Jon Amund
Publicado: (2022)

Overhauling CAR T Cells to Improve Efficacy, Safety and Cost
por: Chicaybam, Leonardo, et al.
Publicado: (2020)

Crosstalk between autophagy and metabolic regulation of (CAR) T cells: therapeutic implications
por: Panahi Meymandi, Ahmad Reza, et al.
Publicado: (2023)

Rewiring mitochondrial metabolism to counteract exhaustion of CAR-T cells
por: Huang, Yue, et al.
Publicado: (2022)

PD-L1/PD-1: new kid on the “immune metabolic” block
por: Qorraj, Mirjeta, et al.
Publicado: (2017)

CAR-T Cells: Future Perspectives
por: Charrot, Sarah, et al.
Publicado: (2019)

The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
por: Liu, Dongfang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_79g119q0tam9i8l9mm0k257ptj